Current News

LRF-funded Researcher’s Findings Published

                  Wei Du, M.D., Ph.D. and colleagues may have found a link between how stem cells make energy and Fanconi anemia, a disease that us usually diagnosed in children, who sometimes develop leukemia. Doctor Du’s findings could not only improve treatment but

LRF-funded Researcher Leads Team in Understanding Function of Rare Cells in Bone Marrow

                  Iannis Aifantis, Ph.D., professor and chair of the Department of Pathology at the Perlmutter Cancer Center at NYU Langone Health, and colleagues have discovered how rare blood cell types within the bone marrow microenvironment function. Understanding

LRF-funded Researcher Earns $1,187,006 Grant

                  Congratulations to Austin L. Brown, Ph.D., MPH for earning a 1,887,006 grant from the Cancer Prevention and Research Institute of Texas. Doctor Brown was funded by the Leukemia Research Foundation in 2017 for his research on acute lymphoblastic

Leukemia Research Foundation Earns Charity Navigator “4-Star Charity” Rating for the Third Time

(Northfield, Ill. – February 14, 2019) - The Leukemia Research Foundation proudly announces that for the third time in five years it has earned the coveted “4-Star Charity” rating from Charity Navigator, the highest possible rating from America’s largest national independent charity evaluator.

Super Heroes, Tommy Hawk and Therapy Dogs Highlight Party for Pediatric Blood Cancer Patients

Chicago Blackhawks mascot Tommy Hawk made a guest appearance at the Leukemia Research Foundation’s Kids’ Party. Patients were the superheroes at the Leukemia Research Foundation’s (LRF) Annual Kids’ Party. More than 120 guests including 35 pediatric patients enjoyed a fun morning filled with

LRF Medical Advisory Board Member and Patient Program Presenter Makes Key Finding on Newer CLL Medication

              Scott Smith, M.D., Ph.D. FACP is co-author of a study that found that a newer targeted medication called ibrutinib is more effective at treating chronic lymphocytic leukemia (CLL) in some patients than the current standard therapy. Read more about the finding

LRF-funded Researcher Presents Findings at ASH

                  Bruno Paiva, PharmD, Ph.D., head of the Flow Cytometry Laboratory and co-coordinator, Center for Applied Medical Research (CIMA) LAB Diagnostics at the University of Navarra in Pamplona, Spain, presented findings of research impacting elderly acute

Two LRF-funded Researchers Earn ASH Award

Researchers’ work currently being funded by the Leukemia Research Foundation. NORTHFIELD, Ill., December 11, 2018 – The Leukemia Research Foundation congratulates Esther Obeng, M.D., Ph.D., Assistant Member, St. Jude Children's Research Hospital, and Russell Ryan, M.D., Assistant Professor at

LRF-Funded Researcher Discovers Link Between Helios Protein and Two Blood Cancers

                  Michael Kharas, Ph.D., associate member at the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center, and colleagues have discovered how the protein called Helios impacts a pediatric blood cancer called B-acute lymphoblastic

LRF-funded Researcher Earns NIH Grant

                  Matthew J. Walter M.D., professor, Department of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia Stem Cell Biology at the Washington University School of Medicine in St. Louis, Mo., has earned a grant from the National Institutes